Erlogem-150 Tablet Substitute
RXAllieva Pharma Pvt Ltd
₹292.5
(₹9.75 per unit)
RXGLS Pharma Ltd
₹211
(₹21.1 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹891.79
(₹80.26 per unit)
RXZydus Cadila
₹3431
(₹93.78 per unit)
RXHetero Drugs Ltd
₹4114.5
(₹112.46 per unit)
RX₹7200
(₹196.8 per unit)
RX₹7200
(₹196.8 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹2340
(₹210.6 per unit)
RXNatco Pharma Ltd
₹8768.5
(₹239.67 per unit)
RXMylan Pharmaceuticals Pvt Ltd
₹11900
(₹325.27 per unit)
RXMedion Biotech Pvt Ltd
₹10600
(₹353.33 per unit)
RXAxiommax Oncology Pvt Ltd
₹4443.5
(₹444.35 per unit)
RXSamarth Life Sciences Pvt Ltd
₹7000
(₹574.0 per unit)
RXAureate Pharma
₹29752.4
(₹2439.7 per unit)
RXAarmac Lab
₹5750
(₹4715.0 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Erlogem-150 Tablet to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - ERLOTINIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Erlogem-150 Tablet is used in the treatment of cancer. The detailed uses of Erlogem-150 Tablet are as follows:
Erlogem-150 Tablet is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Erlogem-150 Tablet travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Erlogem-150 Tablet contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Erlogem-150 Tablet targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Erlogem-150 Tablet stops the production, spread, and growth of cancerous cells in the body.
The substitutes of Erlogem-150 Tablet contain the same active salt(s) - ERLOTINIB-150MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Erlogem-150 Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Erlogem-150 Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Erlogem-150 Tablet meet the same safety and efficacy standards as Erlogem-150 Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Erlogem-150 Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Erlogem-150 Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Erlogem-150 Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Erlogem-150 Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Erlogem-150 Tablet to its substitute. Always consult your doctor before switching.
Erlogem-150 Tablet is used to treat lung and pancreatic cancer.
Erlogem-150 Tablet contains Erlotinib, an anti-cancer medication that works by preventing the activity of a protein called epidermal growth factor receptor (EGFR) and hence induces cell death (apoptosis). As a result, the growth and spread of cancer cells in stopped or slowed down.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.
Erlogem-150 Tablet is safe to be taken by a diabetic person. However, take Erlogem-150 Tablet only after asking with a doctor as they may adjust the dosing according to the patient's condition.
In elderly patients, the risk of side effects is more if you are taking Erlogem-150 Tablet . For the patients who are elderly, dose adjustment might be required or your doctor might prescribe any other medication safe for the elderly.
Erlogem-150 Tablet can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details.
No, It is advised to maintain a gap between both the medicines, as use of antacids along with Erlogem-150 Tablet may affect the way the Erlogem-150 Tablet works. Consult your doctor for further information.
Erlogem-150 Tablet should be used with caution in patients using anticoagulants. Erlogem-150 Tablet may increase your tendency to bleed. Talk to your doctor, he will need to regularly monitor you with some blood tests.
Erlogem-150 Tablet is not recommended for children under 18 years of age, as its safety and efficacy were not established.
No, you should not take Erlogem-150 Tablet if you are pregnant or planning to become pregnant as it may cause harm to an unborn baby. Consult the doctor if you have any concerns.
No, do not take Erlogem-150 Tablet with food. It can be taken orally on an empty stomach, at least 1 hour before or 2 hours after meals.
Erlogem-150 Tablet is a targeted therapy used to treat specific types of non-small cell lung cancer that spread to nearby tissues or any other parts of the body in patients who have previously undergone at least one chemotherapy treatment without improvement.
Erlogem-150 Tablet should be taken for as long as your doctor has prescribed it, depending on your medical condition. Please consult the doctor if you have any concerns regarding the duration of treatment.
Yes, Smoking may interfere with Erlogem-150 Tablet . It lowers the levels of Erlogem-150 Tablet in the blood, potentially reducing its effectiveness in treating the cancer. Avoid smoking while on treatment with Erlogem-150 Tablet to treat your condition effectively.
Inform the doctor if you notice a rash while taking Erlogem-150 Tablet as it could be a symptom of an allergic reaction.
Erlogem-150 Tablet may harm the foetus. Therefore, it is not recommended to become pregnant during treatment with Erlogem-150 Tablet . Use effective birth control while taking Erlogem-150 Tablet and for at least one month after your final dose. Talk to the doctor if you plan to become pregnant; the doctor will provide guidance on the same.
Erlogem-150 Tablet may cause sparse eyelashes (thinning of eyelashes), blepharitis (inflammation of eyelids), and diffuse conjunctival congestion (redness of the eye). Consult the doctor if you notice any eye problems.
Call your doctor if you experience severe diarrhoea, nausea, vomiting, loss of appetite, worsening shortness of breath or cough, new or worsening rash, blistering or peeling of the skin, eye irritation or any changes in smoking habits during treatment with Erlogem-150 Tablet .
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd